Journal Article (Letter)

DKFZ-2023-00858

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Re: Ana Cavillon, Damien Pouessel, Nadine Houédé, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.011.

Zhao, B. (First author)DKFZ* ; Zhang, R.DKFZ* ; Wu, J.

2023
Elsevier Science Amsterdam [u.a.]

Note: #EA:D170# / 2023 Jul;84(1):e20-e21

---

Contributing Institute(s):

1. KKE Neuroimmunologie und Hirntumorimmunologie (D170)
2. DKTK HD zentral (HD01)
3. E230 Medizinische Bildverarbeitung (E230)

Research Program(s):

1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2023

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 20 ; JCR ; National-Konsortium ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---